首页>
外国专利>
CLINICAL UTILIZATION OF CONTRAST AGENTS TO DEFINE SPECIFIC AREAS WITHIN THE MYOCARDIAL WALL TO PROVIDE GUIDANCE AND LOCALIZATION FOR ABLATION, CYROABLATION, OR OTHER TECHNIQUES IN PATIENTS WITH POST MYOCARDIAL INFARCTION
CLINICAL UTILIZATION OF CONTRAST AGENTS TO DEFINE SPECIFIC AREAS WITHIN THE MYOCARDIAL WALL TO PROVIDE GUIDANCE AND LOCALIZATION FOR ABLATION, CYROABLATION, OR OTHER TECHNIQUES IN PATIENTS WITH POST MYOCARDIAL INFARCTION
Certain embodiments of the present invention provide systems and methods for ablating non-viable cardiac tissue. In an embodiment, the method may include locating non-viable cardiac tissue utilizing an electronic medical image. The method may also include locating non-viable cardiac tissue utilizing an ultrasound unit, wherein a contrast agent is used to characterize the non-viable cardiac tissue. The method may also include guiding a catheter to the location of the non-viable cardiac tissue according to the imaging of the ultrasound unit. The method may also include ablating the non-viable cardiac tissue. The ablating of the non-viable cardiac tissue may include cauterizing the non-viable cardiac tissue, cyroablating the non-viable cardiac tissue, or include radiofrequency ablation. The method may also include attempting to locate the non-viable cardiac tissue utilizing an electronic medical image after ablating the non-viable cardiac tissue.
展开▼
